Literature DB >> 8002940

Cardiac adenylate deaminase: molecular, kinetic and regulatory properties under phosphate-free conditions.

J K Thakkar1, D R Janero, H M Sharif, D Hreniuk, C Yarwood.   

Abstract

Adenylate deaminase (EC 3.5.4.6) may help to regulate the adenine nucleotide catabolism characteristic of such disease states as myocardial ischaemia. We report analysis of the molecular, kinetic and allosteric properties of rabbit heart adenylate deaminase when extracted and purified under phosphate-free conditions (i.e., with Hepes/KOH). The enzyme's subunit molecular mass (approximately 81 kDa), pI (6.5), substrate specificity for 5'-AMP, and activation by K+ were identical in the absence or presence of phosphate. At each chromatographic step during isolation without phosphate, cardiac adenylate deaminase showed a lower apparent activity as compared with the enzyme prepared with phosphate present. Kinetic constants for the phosphate-free rabbit heart adenylate deaminase preparation (Km 0.54 mM AMP; Vmax. 1.4 mumol/min per mg of protein) were approximately 10-fold lower than those of the enzyme isolated with phosphate. The same irreversible decrease in kinetic constants could be achieved by dialysing phosphate from the phosphate-containing enzyme preparation. The relationship between enzyme activity and substrate concentration was sigmoidal in the presence of phosphate, but hyperbolic in its absence. Cardiac adenylate deaminase under phosphate-free conditions was no longer allosterically activated by ATP and ADP, yet remained inhibitable by GTP. Enzyme inhibition by the transition-state mimic coformycin was not influenced by phosphate status. The phosphate-free preparation of rabbit heart adenylate deaminase was markedly labile and extremely susceptible to proteolysis by trypsin or chymotrypsin. The inactivation kinetics and fragmentation pattern in response to controlled proteolysis depended on whether the enzyme had been isolated with or without phosphate present, suggesting a conformational difference between the two enzyme preparations. These data constitute direct evidence that the absence of phosphate irreversibly converts cardiac adenylate deaminase into a pseudo-isoenzyme with distinct kinetic, regulatory and stability properties.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8002940      PMCID: PMC1138170          DOI: 10.1042/bj3000359

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  A spectrophotometric determination of trypsin and chymotrypsin.

Authors:  G W SCHWERT; Y TAKENAKA
Journal:  Biochim Biophys Acta       Date:  1955-04

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Catalytic and regulatory site composition of yeast AMP deaminase by comparative binding and rate studies. Resolution of the cooperative mechanism.

Authors:  D J Merkler; V L Schramm
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

4.  Isolation and characterization of AMP deaminase from mammalian (rabbit) myocardium.

Authors:  J K Thakkar; D R Janero; C Yarwood; H Sharif; D Hreniuk
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

5.  An improved purification, crystallization, and some properties of rabbit muscle 5'-adenylic acid deaminase.

Authors:  K L Smiley; A J Berry; C H Suelter
Journal:  J Biol Chem       Date:  1967-05-25       Impact factor: 5.157

6.  Changes in AMP deaminase activities in the hearts of diabetic rats.

Authors:  R L Jenkins; H G McDaniel; L Atkins
Journal:  Biochim Biophys Acta       Date:  1991-04-29

7.  Ammonia production in muscle: the purine nucleotide cycle.

Authors:  J Lowenstein; K Tornheim
Journal:  Science       Date:  1971-01-29       Impact factor: 47.728

8.  Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): nonperoxidative purine and pyrimidine nucleotide depletion.

Authors:  D R Janero; D Hreniuk; H M Sharif
Journal:  J Cell Physiol       Date:  1993-06       Impact factor: 6.384

9.  Effect of 5'-deoxy-5'-isobutylthioadenosine on formation and release of adenosine from neonatal and adult rat ventricular myocytes.

Authors:  P Meghji; A C Skladanowski; A C Newby; L L Slakey; J D Pearson
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

10.  Modulation of mammalian cardiac AMP deaminase by protein kinase C-mediated phosphorylation.

Authors:  J K Thakkar; D R Janero; C Yarwood; H M Sharif
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

View more
  3 in total

1.  Mammalian-heart adenylate deaminase: cross-species immunoanalysis of tissue distribution with a cardiac-directed antibody.

Authors:  J K Thakkar; D R Janero; H M Sharif; C Yarwood
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396

2.  Oxidative modulation and inactivation of rabbit cardiac adenylate deaminase.

Authors:  D R Janero; C Yarwood
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

Review 3.  Role of the HPRG Component of Striated Muscle AMP Deaminase in the Stability and Cellular Behaviour of the Enzyme.

Authors:  Francesca Ronca; Antonio Raggi
Journal:  Biomolecules       Date:  2018-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.